文献速递耳科与耳神经

临床样本中耳病「红旗征」检测的回顾性评估

A Retrospective Estimate of Ear Disease Detection Using the "Red Flags" in a Clinical Sample.
PubMed 文献 · Ear Hear · 2018-01-01

本研究在梅奥诊所佛罗里达院区回顾性分析251例成人病历,以神经耳科医生诊断为金标准,评估两套红旗征方案检测听力相关耳病的敏感性与特异性。结果显示FDA红旗征敏感性91%、特异性72%,AAO-HNS红旗征敏感性98%、特异性仅20%。

要点

  • FDA红旗征敏感性91%、特异性72%,AAO-HNS方案敏感性98%但特异性仅20%。
  • 两套方案对听力相关耳病的检测性能差异显著,需权衡漏诊与误诊。
  • 直接面向消费者的助听器模式增加,需不依赖医生介入的耳病检测方法。

核心结论

  • 利益相关方需确定哪些疾病是助听器使用的有意义禁忌证,并判断两套红旗征方案的敏感性与特异性是否可接受。

研究设计与样本

  • 回顾性病历审查,纳入梅奥诊所佛罗里达院区耳鼻咽喉科与听力学科的307例成人患者,为另一项研究招募的便利样本,最终251份病历纳入分析。
  • 以神经耳科医生诊断作为比较标准。

主要发现

  • 251例中191例有一种或多种目标疾病,60例为年龄或噪声相关听力损失。
  • FDA红旗征敏感性91%(CI 86至95%),特异性72%(CI 59至83%)。
  • AAO-HNS红旗征敏感性98%(CI 95至99%),特异性20%(CI 11至32%)。

关键数值与推荐

  • FDA红旗征:敏感性91%(CI 86至95%),特异性72%(CI 59至83%)。
  • AAO-HNS红旗征:敏感性98%(CI 95至99%),特异性20%(CI 11至32%)。

临床怎么用

  • 在助听器验配或直接面向消费者的听力设备场景中,可参考红旗征方案筛查听力相关耳病,但需注意AAO-HNS方案特异性低、假阳性多。

局限性

  • 回顾性病历审查设计,样本为便利样本,来自单一机构。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The purpose of this study was to evaluate the specificity and sensitivity of two red flag protocols in detecting ear diseases associated with changes in hearing. DESIGN: The presence of red-flag symptoms was determined in a chart review of 307 adult patients from the Mayo Clinic Florida Departments of Otorhinolaryngology and Audiology. Participants formed a convenience sample recruited for a separate study. Neurotologist diagnosis was the criterion for comparisons. RESULTS: Of the 251 patient files retained for analysis, 191 had one or more targeted diseases and 60 had age- or noise-related hearing loss. Food and Drug Administration red flags sensitivity was 91% (confidence interval [CI], 86 to 95%) and specificity was 72% (CI, 59 to 83%). American Academy of Otolaryngology-Head and Neck Surgery red flags sensitivity was 98% (CI, 95 to 99%) and specificity was 20% (CI, 11 to 32%). CONCLUSIONS: Stakeholders must determine which diseases are meaningful contraindications for hearing aid use and whether these red-flag protocols have acceptable levels of sensitivity and specificity. As direct-to-consumer models of hearing devices increase, a disease detection method that does not require provider intercession would be useful.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Klyn NAM, Kleindienst Robler S, Alfakir R, et al. A Retrospective Estimate of Ear Disease Detection Using the "Red Flags" in a Clinical Sample. Ear Hear. 2018. PMID: 29498954. doi:10.1097/AUD.0000000000000561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。